Effects of HIV aspartyl-proteinase inhibitors on Leishmania sp. |
| |
Authors: | Elizabeth Valdivieso Ariadne Rangel Jose María Saugar Jorge Alvar |
| |
Institution: | a Laboratorio de Biología Celular de Parásitos, Instituto de Biología Experimental, Universidad Central de Venezuela, Caracas 1041-A, Venezuela b World Health Organization Collaborating Centre for Leishmaniasis, Servicio de Parasitología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Mahadahonda (Madrid), Spain c Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland |
| |
Abstract: | In this work, we have found an antiproliferative effect on Leishmania sp. promastigotes and axenic amastigotes by the human immunodeficiency virus (HIV) aspartyl-proteinase inhibitors, Ac-Leu-Val-Phenylalaninal, Saquinavir mesylate and Nelfinavir, the latter two being used as part of antiretroviral therapy. This effect appears to be the result of cell division blockage. In addition, these drugs induced in culture a decrease in the percentage of co-infected HIV/Leishmania monocytes and amastigotes of Leishmania per macrophage. The finding of a dose-dependent inhibition of Leishmania promastigotes aspartyl-proteinase activity by these drugs allows us to propose this activity as the drug parasite target. A direct action of these HIV aspartyl-proteinase inhibitors on the parasite, would be correlated with the effect that highly active antiretroviral therapy have had in the decrease of HIV/Leishmania coinfection, opening an interesting perspective for new drugs research development based on this novel parasite proteinase family. |
| |
Keywords: | Leishmania Aspartyl proteinase HIV Nelfinavir Saquinavir mesylate Ac-Leu-Val-Phenyalaninal |
本文献已被 ScienceDirect 等数据库收录! |
|